GlassScriptPhysician profile
Afua Mintah
NPI 1649413501
$1,082.45
in general payments reported to CMS, 2019-2025
27 companies · $341 in 2025
The $341 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $87.12 · 2021: $76.17 · 2022: $87.36 · 2023: $188 · 2024: $199 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $637.60 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $120.37 | 2025 | Intrarosa, Femlyv |
| Davol INC. | $98.49 | 2021-2024 | Arista Ah Flexitip |
| Myriad Women'S Health, INC. | $80.05 | 2023 | Myrisk |
| Abbvie INC. | $74.62 | 2021-2023 | |
| Pfizer INC. | $67.65 | 2022-2025 | |
| Sage Therapeutics, LLC | $62.27 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $61.13 | 2024-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $58.82 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.37 | 2019-2020 | |
| Astellas Pharma US INC | $56.03 | 2019-2023 | Veozah |
| Hologic Sales and Service, LLC | $49.47 | 2023-2025 | Thinprep 2000 Processor, Aptima, Novasure |
| Exeltis, USA INC. | $33.47 | 2025 | Slynd |
| Supernus Pharmaceuticals, INC. | $24.02 | 2025 | Qelbree |
| Myovant Sciences INC. | $24.00 | 2022 | |
| Smith+Nephew, INC. | $22.86 | 2024 | Stravix Pl, Stravix Mesh |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $21.30 | 2025 | |
| Mimedx Group, INC. | $21.16 | 2024 | |
| Amgen INC. | $17.94 | 2019 | |
| Covidien LP | $17.91 | 2020 | |
| Therapeuticsmd, INC. | $17.05 | 2020 | |
| Evofem Biosciences, INC. | $16.76 | 2022 | |
| Amarin Pharma, INC. | $14.85 | 2019 | |
| Exact Sciences Corporation | $14.20 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $13.35 | 2020 | |
| Genzyme Corporation | $12.98 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.18 | 2020 | |
| Janssen Pharmaceuticals, INC | $12.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Afua Mintah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.